# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Although the settlement has been reached, Johnson & Johnson still faces a substantial number of talc-related lawsuits.
- Reuters Citing Court Documents
- Reuters Citing Court Documents
- Reuters
Humira maintains over 80% of its market share despite facing nine biosimilar rivals, raising concerns about the future of the b...
https://www.jnj.com/media-center/press-releases/depuy-synthes-receives-510k-fda-clearance-of-the-velys-robotic-assisted-solutio...